DEAR ABBY: My boyfriend passed away 15 months ago. I have been devastated ever since. He was my best friend, and I’m having a hard time letting go. He said he would love me even in death, and when he ...

As he stares down his 46th birthday this summer, Justin Rose is the oldest player in the Official World Golf Rankings top 50 — and that experience isn’t lost on him. In fact, his past experience is ...

The Education Department has until Sept. 30 to spend about $289 million on education research or the money could be returned to the U.S. Treasury, according to a memo from the Knowledge Alliance, a ...

NEW ALBANY, Ohio — A major investment in central Ohio is offering a real-time look at how large-scale manufacturing is evolving to meet rising sustainability expectations. Amgen is expanding its ...

People who are sex trafficked are often branded with names and symbols. Free removal programs are helping them move on. For 17 years, Kathy Givens carried her trafficker’s name on her back — a ...

Add Yahoo as a preferred source to see more of our stories on Google. I am in the process of reconnecting with a past partner—the only man I’ve ever really loved. It’s been almost 20 years of being ...

I am in the process of reconnecting with a past partner—the only man I’ve ever really loved. It’s been almost 20 years of being apart and speaking every few years. He’s 71 and retired, and I’m 59 and ...

The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. More than a third ...

Sustainable trims have gained momentum in recent years as brands and suppliers begin to confront one of fashion’s more functional blind spots: the small components (and the data attached to them) that ...

On Sunday, Burrows retired his first 14 batters in a row before his outing derailed. Five straight hitters reached with two outs in the fifth. Two did so with ground-ball singles, but two others ...

Drug discovery is entering a new phase of complexity. From peptides and oligonucleotides to targeted protein degraders and other emerging modalities, many of today’s therapies require advanced ...

There are plenty of big names that have taken a beating so far this year. Many of the market losses aren't warranted. Investors should assess a company's underlying strength before making a move. I ...